Metraipolis › archive › dc_0411ce30883a
Intralesional bevacizumab as an adjuvant approach to recurrent respiratory papillomatosis: A prospective study on different treatment protocols — Europe PMC PMID:41701700
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41701700
- DOI
- 10.1371/journal.pone.0342749
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T16:59:48.734Z
- SHA-256 of the archived text
7264c2b8a7feb7c858a0834296dca3f5c59c5370f0a1bc2a33d3461f5c02ffbe- Stable URL of this page
https://metraipolis.com/documento/dc_0411ce30883a
How to cite
Intralesional bevacizumab as an adjuvant approach to recurrent respiratory papillomatosis: A prospective study on different treatment protocols — Europe PMC PMID:41701700 — Europe PMC (en), https://europepmc.org/article/MED/41701700 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0411ce30883a (Metraipolis archive dc_0411ce30883a, sha256 7264c2b8a7feb7c858a0834296dca3f5c59c5370f0a1bc2a33d3461f5c02ffbe)
BibTeX
@misc{dc0411ce30883a,
title = {Intralesional bevacizumab as an adjuvant approach to recurrent respiratory papillomatosis: A prospective study on different treatment protocols — Europe PMC PMID:41701700},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41701700},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0411ce30883a; sha256 7264c2b8a7feb7c858a0834296dca3f5c59c5370f0a1bc2a33d3461f5c02ffbe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41701700. Agents can read the archived copy with the MCP tool read_document.